UBS Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101M | Buy |
|
|||||
|
2025
Q1 | $92.5M | Buy |
|
|||||
|
2024
Q4 | $64.2M | Buy |
|
|||||
|
2024
Q3 | $58M | Buy |
|
|||||
|
2024
Q2 | $49.4M | Sell |
|
|||||
|
2024
Q1 | $72.2M | Buy |
|
|||||
|
2023
Q4 | $32M | Sell |
|
|||||
|
2023
Q3 | $47.5M | Sell |
|
|||||
|
2023
Q2 | $83.6M | Buy |
|
|||||
|
2023
Q1 | $45M | Buy |
|
|||||
|
2022
Q4 | $41.9M | Buy |
|
|||||
|
2022
Q3 | $20.2M | Sell |
|
|||||
|
2022
Q2 | $44.4M | Buy |
|
|||||
|
2022
Q1 | $42.4M | Sell |
|
|||||
|
2021
Q4 | $55.7M | Sell |
|
|||||
|
2021
Q3 | $64.3M | Sell |
|
|||||
|
2021
Q2 | $86.8M | Buy |
|
|||||
|
2021
Q1 | $72.8M | Sell |
|
|||||
|
2020
Q4 | $74.9M | Buy |
|
|||||
|
2020
Q3 | $56.1M | Buy |
|
|||||
|
2020
Q2 | $47.6M | Sell |
|
|||||
|
2020
Q1 | $42.5M | Buy |
|
|||||
|
2019
Q4 | $51.1M | Buy |
|
|||||
|
2019
Q3 | $41.3M | Buy |
|
|||||
|
2019
Q2 | $20.9M | Sell |
|
|||||
|
2019
Q1 | $44.2M | Buy |
|
|||||
|
2018
Q4 | $25M | Sell |
|
|||||
|
2018
Q3 | $33.2M | Buy |
|
|||||
|
2018
Q2 | $26.2M | Sell |
|
|||||
|
2018
Q1 | $41.3M | Sell |
|
|||||
|
2017
Q4 | $56.5M | Buy |
|
|||||
|
2017
Q3 | $26.4M | Sell |
|
|||||
|
2017
Q2 | $134M | Buy |
|
|||||
|
2017
Q1 | $22M | Sell |
|
|||||
|
2016
Q4 | $26.7M | Buy |
|
|||||
|
2016
Q3 | $24.6M | Sell |
|
|||||
|
2016
Q2 | $22.9M | Buy |
|
|||||
|
2016
Q1 | $17.2M | Sell |
|
|||||
|
2015
Q4 | $17.7M | Buy |
|
|||||
|
2015
Q3 | $14.7M | Buy |
|
|||||
|
2015
Q2 | $16.3M | Sell |
|
|||||
|
2015
Q1 | $21.1M | Buy |
|
|||||
|
2014
Q4 | $11.4M | Buy |
|